尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Smith Robin L. Insider active across 2 companies, notably Sorrento Therapeutics, Inc.. Cumulatively, 3 reports have been logged. Activity tracked since 3 September 2021. The latest transaction was filed on 14 June 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Smith Robin L is a declarant linked to Celularity Inc and Sorrento Therapeutics, Inc., where the listed role is Director. The total number of filings is 4, and across the recent filings available, the modal transaction nature is Attribution, with amounts of EUR 249442.5085044571 on 2021-09-03 for Sorrento Therapeutics, Inc. and EUR 0 for Celularity Inc between 2022-07-15 and 2023-06-16.